The QualityStocks Daily Thursday, July 15th, 2021

Today's Top 3 Investment Newsletters

MarketClub Analysis(RECAF) $4.4095 +58.05%

QualityStocks(IPSI) $0.1385 +54.84%

NetworkNewsWire(PRPI) $0.2700 +35.00%

The QualityStocks Daily Stock List

Yiren Digital (YRD)

VectorVest, StreetInsider, MarketBeat, Zacks, Trading Concepts, The Street, MarketClub Analysis, BUYINS.NET, StockMarketWatch, Short Term Wealth, Seeking Alpha, InvestorPlace, Investing Futures and Cabot Wealth reported earlier on Yiren Digital (YRD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in March 2012 by Ning Tang. Prior to its name change in September 2019, the firm was known as Yirendai Ltd. The firm is a subsidiary of Creditease Holdings Ltd and operates as part of the financial sector, under the financial services industry in the specialty finance sub-industry.

The company operates through the Grade I, Grade II, Grade III and Grade IV segments. It carries out its operations in the country through Heng Cheng Technology Co. Ltd, which is its consolidated variable interest entity; and Yi Ren Heng Ye Technology Co. Ltd.

The enterprise’s online marketplace provides vertical and express loan products as well as standard loan products to borrowers. These products can be used in continuing education, travel and home remodels. It also offers post-origination services like SMS services, cash collection and processing, as well as loan facilitation services. The enterprise’s loan products portfolio includes secured consumer loans and unsecured consumer loans. In addition to this, the enterprise provides online investor education services, customer support, system maintenance and IT services and other training programs on consultancy information technology support, investment strategies, market insights and wealth planning.

The company recently announced its financial results for the first quarter of 2021, with its CEO noting that they were focused on the firm’s strategic direction and were working to address the consumers’ financial needs, which would in turn drive growth and expand their business map.

Yiren Digital (YRD), closed Thursday’s trading session at $5.07, up 0.996016%, on 79,646 volume. The average volume for the last 3 months is 290,266 and the stock's 52-week low/high is $2.70000004/$6.80000019.

GasLog Partners (GLOP)

The Online Investor, MarketBeat, StreetInsider, Daily Trade Alert, MarketClub Analysis, Marketbeat.com, Trades Of The Day, InvestorPlace, Zacks, The Street, Short Term Wealth, BUYINS.NET, TopStockAnalysts, Investiv, Investing Daily and Schaeffer's reported earlier on GasLog Partners (GLOP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Piraeus, Greece and was incorporated in 2013, on January 23rd. It operates in the industrials sector, under the industrial services industry, in the transportation and logistics sub-industry and serves consumers across the globe.

The company operates its business through the single owning and operating liquefied natural gas carriers segment. Its fleet includes steam vessels and vessels that operate under long-term charters.

As of March 2021, the enterprise operates a fleet of LNG carriers which have a median carrying capacity that ranges between 145,000 and 155,000 m3. The fleet comprises of Methane Heather Sally, Solaris, Methane Shirley Elisabeth, GasLog Sydney, Methane Alison Victoria, GasLog Santiago, Methane Jane Elizabeth, GasLog Shanghai, Methane Rita Andrea and GasLog Seattle. Every GasLog vessel has a cargo capacity of about 155,000 m3 while every Methane vessel has a cargo capacity of roughly 145,000 m3.

The company recently entered into a duo of new time charter agreements with leading global energy producers, namely a Royal Dutch Shell Plc. subsidiary and a Total S.A. subsidiary, for its Solaris and GasLog Sydney carriers which have a carrying capacity of 155,000 m3 each. These new charters will help improve the company’s cash flow visibility and revenue, which will in turn balance its financial and operational leverage, thereby attracting more investors.

GasLog Partners (GLOP), closed Thursday’s trading session at $4.98, up 1.2195%, on 553,406 volume. The average volume for the last 3 months is 1.132M and the stock's 52-week low/high is $2.0999999/$5.92999982.

Osmotica Pharmaceuticals (OSMT)

TradersPro, MarketBeat, StreetInsider, StockMarketWatch, The Street, MarketClub Analysis, TrendAdvisor, SystemTrading and BUYINS.NET reported earlier on Osmotica Pharmaceuticals (OSMT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm is based in Bridgewater, New Jersey and was incorporated in 1986. It operates as part of the pharmaceutical manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry. The firm has seven companies in its corporate family and serves consumers and patients in Hungary, Argentina and the U.S., as well as internationally.

The company utilizes its proprietary osmotic technology platform to develop and commercialize high quality pharmaceutical products in collaboration with its strategic partners.

The enterprise’s pipeline comprises of an oxymetazoline hydrochloride ophthalmic solution indicated for treating Blepharoptosis dubbed Upneeq; an amantadine extended release tablet indicated for the treatment of drug-induced extrapyramidal reactions in grownups and Parkinson’s disease, dubbed Osmolex ER; a methylphenidate hydrochloride extended-release tablet to treat ADHD known as M-72; and a formulation currently undergoing phase 1 trials evaluating its efficacy in treating neurodegenerative disorders known as OS870. It also offers women’s health products, including a dietary supplement for postnatal, pregnancy and prenatal periods dubbed OB Complete and Divigel for menopause. In addition to this, the enterprise also develops a tramadol hydrochloride for pain management known as ConZip; a formulation for overactive bladders known as oxybutynin; sodium phenylacetate/sodium benzoate for treating hyperammonemia and a formulation for hypertension known as nifedipine ER.

The company recently entered into a definitive sale and purchase agreement with Alora Pharmaceuticals LLC. The move will be helpful in the company’s transformation as it aligns with the firm’s strategy of building a portfolio of ocular aesthetics, which may bring in more investments into the firm.

Osmotica Pharmaceuticals (OSMT), closed Thursday’s trading session at $3.25, off by 1.5152%, on 334,125 volume. The average volume for the last 3 months is 1.313M and the stock's 52-week low/high is $2.70000004/$6.5999999.

Weidai (WEI)

StreetInsider, MarketClub Analysis, Trading Concepts, TradersPro, QualityStocks and MarketBeat reported earlier on Weidai (WEI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Hangzhou, the People’s Republic of China and was incorporated in February 2010 by Hong Yao. It operates as part of the consulting services industry, under the financial sector, in the specialty finance sub-industry. The firm has four companies in its corporate family.

The peer-to-peer lending company’s objective is to provide micro and small enterprise owners with accessible credit, seeing as it’s the first company in the country to introduce auto-backed financing products. It maintains an effective and sophisticated risk management system that spans across its whole transaction process. The company generates revenue from the service fees that borrowers are charged for management and facilitation of loans and the firm believes that its services and products create exceptional value for both investors and borrowers.

The enterprise is the biggest auto-backed financing solution provider in terms of loan volume in the country and operates a platform which connects borrowers, the majority of whom are micro and small enterprise owners, with both institutional funding partners and online investors. Its extensive offline network, which integrates seamlessly with the enterprise’s centralized technology platform and risk management system, has allowed for fast and highly automated transaction processes. The enterprise uses vehicles as collateral and is planning to offer personal loans as well as use property as collateral in the future.

The firm is well positioned to occupy a larger market share in the Chinese market as it was the first company to introduce auto-backed financing products. This, coupled with its ease of use and access, will help extend the firm’s consumer reach and also bring in more investors into the firm.

Weidai (WEI), closed Thursday’s trading session at $1.09, off by 3.5398%, on 725,862 volume. The average volume for the last 3 months is 3.32M and the stock's 52-week low/high is $0.730000019/$5.48999977.

Wireless Telecom Group (WTT)

Wall Street Resources, StockMarketWatch, TheStockAdvisors, InvestorPlace, MarketBeat, StreetInsider, Zacks, Investing Futures, MarketClub Analysis, MonsterStocksPicks, Barchart, Stock Stars, The Bowser Report, The Online Investor, Wall St Insider Stocks and SmallCapVoice reported earlier on Wireless Telecom Group (WTT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Parsippany, New Jersey and was incorporated in 1985. It operates as part of the technology sector, under the tech hardware and semiconductors industry, in the technology hardware sub-industry.

The company markets its products and serves under the Noisecome, Microlab/FXR, Boonton, Holzworth and CommAgility brands through distributors, manufacturers’ representatives and its in-house sales force. Its products have maintained a reputation for their performance and accuracy as they support consumer technological advancements within communications. The company serves medical device manufacturers, neutral host providers, system integrators, semiconductor companies, tower companies, network equipment manufacturers, satellite communication companies, military and government agencies, aerospace and defense companies and wireless carriers.

The enterprise offers GPS digital splitters and repeaters for cellular timing synchronization; audio and modulation analyzers for electronic warfare, avionics, radar, electromagnetic interference compatibility, wireless and satellite communications applications. It also provides long-term evolution physical layer and stack software for 5G and 4G mobile network applications; embedded signal processing and radio frequency modules; signal generators and noise analyzers.

The company’s Boonton brand recently introduced to the market the SGX1000 RF Signal Generator which combines high-performance signal generation abilities with an intuitive user interface. The product brings high-performance signal generation at an affordable price for general use in various industries and is bound to increase the company’s revenues and encourage more investments into the firm, while also extending the company’s consumer reach.

Wireless Telecom Group (WTT), closed Thursday’s trading session at $2.92, off by 2.99%, on 79,883 volume. The average volume for the last 3 months is 342,203 and the stock's 52-week low/high is $0.980000019/$4.1999998.

Quantum Computing, Inc. (QUBT)

QualityStocks, TradersPro and InvestorPlace reported earlier on Quantum Computing, Inc. (QUBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Company has put together a world-class team of experts in supercomputing, technology, defense, and government. This team is working to develop solutions to world-class problems. It is developing processes to commercialize advances in quantum computing.

Quantum Computing is leveraging its collective expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial and security sectors. It is developing a variety of software applications capable of running on quantum and quantum-inspired hardware from numerous vendors. The Company’s initial emphasis is on the creation of Quantum Finance applications.

Mukai is Quantum Computing’s proprietary middleware environment for developing applications to address complex optimization problems that are NP-hard, often involving multi-dimensional solution spaces with thousands if not hundreds of thousands of variables. The software stack contained in Mukai enables developers to create and deploy applications with superior performance on classical computers and future quantum computers.

Regarding Quantum Asset Allocator, Fund Managers can now use the Company’s quantum asset allocator to take advantage of quantum-inspired techniques to solve the NP-hard problems preventing them from truly optimal portfolio optimization. Concerning Community Detection, the Quantum Community Detector utilizes advanced graph analytics with quantum-inspired techniques to deliver insights into big data structures.

Quantum Computing previously announced the release of version 1.1 of its Mukai middleware with new capabilities delivering higher performance and greater ease of use for subject-matter experts developing quantum-ready applications needing superior performance. The Mukai software stack (released in January of 2020) can be used to solve extremely complex optimization problems.

Quantum Computing also announced it appointed noted IT (Information Technology) expert and industry thought leader, Mr. Majed Saadi, to serve on its Technical Advisory Board. Mr. Saadi brings to Quantum Computing greater than 20 years of executive leadership and experience in strategy development and IT transformation, and also functional knowledge in the domains of cloud computing, platform development, enterprise architecture, and enterprise systems management.

Quantum Computing, Inc. (QUBT), closed Thursday’s trading session at $6.88, up 20.7018%, on 797,806 volume. The average volume for the last 3 months is 80,819 and the stock's 52-week low/high is $2.02010011/$25.0699996.

Cannabis Suisse Corp. (CSUI)

QualityStocks, OTCtipReporter, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, StockOnion, Penny Pick Finders, MicroCapDaily, Buzz Stocks, Penny Picks, HotOTC, Damn Good Penny Picks, BeatPennyStocks and AwesomeStocks reported earlier on Cannabis Suisse Corp. (CSUI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Company was previously known as Geant Corp. It changed its name to Cannabis Suisse Corp. in February of this year. Established in 2016, Cannabis Suisse has its head office in Dietikon, Switzerland.

The Company operates in Europe and pursues new and developing cannabis markets where possible via its own network of wholesale distributors, its e-commerce and mobile applications, brick and mortar retail stores, and grocery store retailers.

Cannabis Suisse provides high CBD tobacco substitutes made from the well-known strains with low THC (tetrahydrocannabinol) and high CBD. The Company extracts CO2 for its own production and for manufacturers/farmers in Switzerland. It clones its own mother plants. As a result, it ensures the quality and taste will be consistent each time customers use its products.

Cannabis Suisse produces chocolate beans, e-cigarette oil, and also tea products with high CBD percentage. Its cannabis is stored in a cool, dark location for optimal results. The ideal storage temperature for the finished dried cannabis product is 2 °C to 6 °C with a shelf-life of 12 months.

The Company has entered into a partnership with Royal Danish Cigars Ltd. This partnership is to develop a luxury product line of cannabis and tobacco blended cigars, marketed under the label SwissCigars™. SwissCigars™ will produce 1 percent THC versions for local consumption and 0.2 percent THC cigars legal for export. These cannabis cigars will be hand rolled in Switzerland by Cuban master rollers. They will subsequently be decorated with 24 KT Swiss Gold and Swarovski.

Cannabis Suisse has strategic investments and Swiss partnerships. With these the Company provides a broad array of first-rate quality cannabis and hemp products, develops unique technologies, promotes cannabis consumer health and wellness, and delivers a premier customer experience with its brand CannaMec™.

Cannabis Suisse previously announced the launching of a new product in its retail brand Alpine Cannabis. Alpine Cannabis CBD Pure Base is an e-liquid for electronic cigarettes. It’s a boost of CBD to any e-liquids. It comes with different levels of CBD strengths.

Alpine Cannabis CBD Pure Base provides Certified CBD concentration in a 10 mL bottle. It is guaranteed without THC and is nicotine free. It contains no alcohol, and no animal extracts and has USP/Food Grade ingredients. The products is tamper-proof and child-proof and diacetyl free and quality controlled.

Cannabis Suisse Corp. (CSUI), closed Thursday’s trading session at $0.07825, up 25.6019%, on 1,722,826 volume. The average volume for the last 3 months is 191,358 and the stock's 52-week low/high is $0.041000001/$0.600000023.

Core One Labs, Inc. (CLABD)

We reported earlier on Core One Labs, Inc. (CLABD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Core One Labs’ emphasis is the California cannabis industry. It is a fully vertically integrated company in the largest cannabis market in North America. The Company has expanding portfolios of proprietary technology and patent-pending intellectual property (IP), combined with a full complement of issued state and municipal permits and licenses. Through its efforts to develop a better CannaStrips™ product, Core One Labs has developed considerable expertise in cannabis extraction and nursery activities.

Core One Labs has the in-house expertise, capability, and capacity to develop and control genetics, grow and mature cannabis biomass, extract and distill cannabinoid actives, manufacture unique products with precisely controlled dosing, distribute wholesale and retail, and transport products throughout the State of California. In complete compliance and with full documentation consistent with existing statutes and regulations, the Company participates in every step, from seed to customer.

Core One Labs previously announced that it entered into a non-binding Letter of Intent (LOI), dated June 4, 2020, with Rejuva Alternative Medicine Research Centre, Inc. and Shahcor Health Services, Inc., wherein the Company proposes to acquire all of the outstanding share capital of Rejuva and one-quarter of the outstanding share capital of Shahcor.

Rejuva and Shahcor are privately-held companies. They operate walk-in medical clinics located in Vancouver and West Vancouver, British Columbia, and maintain a database of greater than 200,000 patients. Core One Labs’ intention is to further develop its product offerings via research and development (R&D) in these clinics.

Core One Labs, Inc. (CLABD), closed Thursday’s trading session at $3.87, up 1136.42%, on 15,256 volume. The average volume for the last 3 months is 37,259 and the stock's 52-week low/high is $0.234999999/$3.86999988.

Jones Soda Co. (JSDA)

QualityStocks, SmarTrend Newsletters, MicrocapVoice, Greenbackers, OTC Picks, CoolPennyStocks, HotOTC, Stock Rich, Hit and Run Candle Sticks, Penny Invest, StockEgg, Stockpalooza, BullRally, Stock Traders Chat, Bull Warrior Stocks, OTCReporter, Stock Analyzer, SuperNova Elite, SmallCapVoice, PennyTrader Publisher, OTCPicks, AllPennyStocks, BestOtc, Bull in Advantage, TopStockAnalysts, TopPennyStockMovers, CRWEPicks, Dividend Opportunities, FNNO Newsletters, StockHotTips, Hidden Stocks, Investor Update, Market Wrap Daily, Marketbeat.com, Momentum Traders, NanoCap Gems, Actual Gains, PricelessPennyStocks, Wealthpire Inc., PoliticsAndMyPortfolio, PennyOmega, PennyStockRumors.net and Stock Fortune Teller reported earlier on Jones Soda Co. (JSDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jones Soda markets and distributes premium beverages under the Jones® Soda and Lemoncocco® brands. Jones Soda is made with pure cane sugar and other high-quality ingredients. Jones Soda is known for packaging that incorporates ever-changing photos sent in from its customers.

The Company’s diverse product line offers pure cane sugar soda, zero-calorie soda and Lemoncocco non-carbonated premium refreshment. Jones sells throughout North America in glass bottles, cans and on fountain through traditional beverage outlets, restaurants, as well as alternative accounts.

Jones Soda’s flavor lineup includes traditional favorites such as Cola, Root Beer, Cream Soda & Orange & Cream. In addition, the Company offers inventive options including Blue Bubblegum, Green Apple, Strawberry Lime and Fufu Berry. The Jones Soda portfolio includes Jones Pure Cane Soda, Jones Sugar Free, Jones Cane Sugar fountain products, Spiked Jones (a hard cider soda created for its 21+ fans) and its sister brand Lemoncocco, which is a non-carbonated beverage inspired by the iconic beverage stands in Rome, Italy.

Recently, JSDA announced that it has issued to SOL Global Investments Corp. (“SOL”) a US$2,000,000 unsecured convertible debenture (the “Convertible Debenture”) and has entered into a non-binding term sheet dated July 14, 2021 (the “Term Sheet”) with Pinestar Gold Inc. (“Pinestar”), a Canadian Reporting Issuer, and SOL. Jones intends to use the proceeds of the Convertible Debenture and transactions outlined in the Term Sheet exclusively for transaction costs and the expansion of Jones’ business to the production and sale of cannabis-containing beverages, edibles and related products.

Jones intends to operate its planned cannabis operations through one or more subsdiaries that are separate from its craft beverage business.

Jones Soda Co. (JSDA), closed Thursday’s trading session at $0.67, up 45.6522%, on 3,374,692 volume. The average volume for the last 3 months is 151,352 and the stock's 52-week low/high is $0.129999995/$0.779999971.

Vitality Biopharma, Inc. (VBIO)

QualityStocks, SmallCap Network, Stock Beast, AwesomeStocks, CFN Media Group, PennyStockScholar, MarketBeat, SmallCapNetwork, The Observer, Buzz Stocks, Planet Penny Stocks, Penny Stock General, Winston Small Cap, Promotion Stock Secrets, Shiznit Stocks, TopPennyStockMovers, Wealth Insider Alert, Investiv, MarketClub Analysis, InvestorSoup, Beacon Equity Research, Journal Transcript, Investing Daily, OTCtipReporter, Outsider Club, Penny Stock Craze, Penny Stocks Finder, PennyStockProphet, ProTrader, SeeThruEquity Research, Stock Preacher, StockHideout, SuperStockTips and PennyPickAlerts reported earlier on Vitality Biopharma, Inc. (VBIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Late in 2015, Vitality successfully modified cannabidiol (CBD), which is not psychoactive. In continuing work, the Company has created a novel class of pharmaceuticals called cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract.

Vitality Biopharma can biosynthesize cannabinoid glycosides (cannabosides) via enzyme biosynthesis. The Company is one of only a very few groups in the world who know how to produce and work with the enzymes that perform glycosylation. It has been focused on it because the same enzymes are used to modify the taste of stevia (steviol glycosides).   

Vitality Biopharma has developed a proprietary biosynthesis technology that can modify cannabinoids to create pharmaceutical prodrugs that have no psychoactivity and that can provide targeted disease treatment. The process involves small molecule glycosylation, where sugar molecules are attached to cannabinoids, creating new compounds called cannabinoid glycosides, or cannabosides.

The Company has introduced its lead cannabinoid drug formulation VITA-100 as a non-psychoactive prodrug of THC. Vitality is centering initial clinical development efforts on VITA-100, a proprietary THC cannabinoid drug formulation. The treatment indications it plans to evaluate in Phase 2 trials include inflammatory bowel disease (IBD), irritable bowel syndrome, and narcotic bowel syndrome (a severe form of opiate-induced abdominal pain).

Recently, announced the filing of national patent applications in the United States and Canada that describe compounds discovered to be effective in a drug screening model for neural repair.

The discoveries included a compound that is known to have a positive track record of safety in clinical trials and to provide pain relief through modulation of the vanilloid TRPV1 receptor. Cannabidiol (CBD), a non-intoxicating cannabinoid independently FDA-approved in pharmaceutical form for the treatment of epilepsy, is also known to relieve pain through modulation of the TRPV1 receptor. As a result, Vitality has made broad patent claims covering use of CBD and other TRPV1 agonists for myelin repair and for treatment of demyelinating disorders.

Vitality Biopharma, Inc. (VBIO), closed Thursday’s trading session at $0.1947, up 27.2133%, on 193,987 volume. The average volume for the last 3 months is 81,333 and the stock's 52-week low/high is $0.05/$0.550000011.

KemPharm Inc. (KMPH)

Schaeffer's, StockMarketWatch, MarketBeat, Barchart, TraderPower, StreetInsider, QualityStocks, Trading Concepts, Streetwise Reports, Marketbeat.com, Investing Futures, INO.com Market Report and BUYINS.NET reported earlier on KemPharm Inc. (KMPH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

For more information, visit www.KemPharm.com

KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT(R) (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT(R) technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm’s prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, (“ADHD”), stimulant use disorder (“SUD”) and CNS rare diseases, including idiopathic hypersomnia (“IH”). KemPharm’s lead clinical development candidate for the treatment of SUD, KP879, is based on its prodrug of d-methylphenidate, known as serdexmethylphenidate (“SDX”). In addition, KemPharm has received FDA approval for AZSTARYS(TM), a new once-daily treatment for ADHD in patents age six years and older, and for APADAZ(R), an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone and acetaminophen. For more information, visit the company’s website at www.KemPharm.com.

KemPharm Inc. (KMPH), closed Thursday’s trading session at $11.3, off by 2.921%, on 782,754 volume. The average volume for the last 3 months is 876,939 and the stock's 52-week low/high is $0.275000005/$18.1499996.

Mastech Digital, Inc. (MHH)

Wall Street Resources, StockMarketWatch, InvestorPlace, Zacks, Barchart, BestOtc, CRWEFinance, CRWEPicks, CRWEWallStreet, alert, MarketBeat, PennyOmega, PennyToBuck, StockHotTips, TopPennyStockMovers and DrStockPick reported earlier on Mastech Digital, Inc. (MHH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mastech Digital (NYSE American: MHH) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “Expect 2Q:21 Results To Showcase The Onset Of A Broad Recovery In MHH’s Business But Year-To-Year EPS Contraction Tied To Higher SG&A Expense And Tax Rate; Maintain $31 Price Target.”

To access the full report, visit https://ibn.fm/srY4G

Mastech Digital is a leading provider of Digital Transformation IT Services.  The Company offers Data Management and Analytics Solutions, Digital Learning, and IT Staffing Services with a Digital First approach.  A minority-owned enterprise, Mastech Digital is headquartered in Pittsburgh, PA with offices across the U.S., Canada, EMEA, India and ASEAN.  Please visit http://www.mastechdigital.com.

Mastech Digital, Inc. (MHH), closed Thursday’s trading session at $15.99, up 0.566038%, on 22,236 volume. The average volume for the last 3 months is 46,188 and the stock's 52-week low/high is $14.00/$25.2600002.

The QualityStocks Company Corner

DealMaker

The QualityStocks Daily Newsletter would like to spotlight DealMaker.

DealMaker was featured in an InvestorNewsBreaks publication detailing various investment considerations and how the company is “One to Watch.” To view the full article, visit https://ibn.fm/bZKZ1

DealMaker is the leading technology solution for companies looking to raise capital faster and more efficiently. Companies of all sizes – from startups to blue chips – use DealMaker to launch and market their offerings to investors across the globe.

DealMaker is the only complete solution for companies raising capital, providing a seamless investor experience and a complete deal CRM with real-time data and analytics, as well as investor management and engagement tools. Companies using DealMaker complete their raises up to 75% faster and over 80% cheaper than traditional methods of capital raising.

Since its founding in 2017, nearly 1,000 capital raises have been completed on DealMaker, including some of the most successful raises in the past three years.

DealMaker has offices in Toronto, Ontario, and Tampa, Florida.

Solutions for Any Type of Capital Raise

A Seamless Investor Journey

Whether investors start their journey by clicking an ‘Invest Now’ link or by receiving a custom email invitation, DealMaker leverages a proprietary question flow that allows investors to complete their subscription agreement in minutes as opposed to hours.

DealMaker digitizes and breaks down the subscription agreement into its core components to ensure investors are only answering the questions relevant to them. This helps to guarantee that investments are secured at the time of interest and with no deficiencies. Companies raising on DealMaker have significantly lower costs, as much as 90% less, due to the elimination of document review and back-and-forth.

Digital Payments, AML and Accredited Investor Verification

The investors’ journey doesn’t end when they sign the subscription agreement. DealMaker has the most robust suite of payment options, including credit card and secure bank-to-bank transfers, to allow investors to pay for their investments immediately and using the methods they prefer. Digital payments increase conversion rates and average investment amounts on every type of deal by removing friction in the payment process.

DealMaker also has automated AML built into the platform – a feature that’s crucial for any marketed raise, including Reg A+ and Crowdfunding, but also anytime investments are accepted from unknown investors. For 506c raises, DealMaker also has Accredited Investor Verification built into the platform, eliminating painful back-and-forth to ensure investors are verified.

In addition to ensuring that the investor has a seamless journey, Digital payments, AML and Accredited Investor Verification efficiently remove the pain of managing payments, background checks and verification from the company raising capital.

A Complete CRM for the Raise

Raising capital can be an arduous process, particularly when it comes to managing back-and-forth and investor follow-up to get the deal closed. DealMaker eliminates that pain by providing a full deal CRM to all companies raising on its platform.

DealMaker offers real-time data on investor progress and payments, automated reminders to drive conversion, contact information and interaction data, as well as tagging and notes to manage investor interactions and follow-ups. DealMaker also offers full payment reconciliation to ensure all books and records are accurate and companies using its technology can close quickly. Companies using DealMaker are able to maximize conversion on their deals and close their raises up to 75% faster.

Additional Benefits of DealMaker

  • Analytics – DealMaker has the most powerful analytical suite on the market. Real-time data provides information at a glance on the performance of the raise, including funnel analytics, conversion, investor progress and payments. DealMaker provides customers with the data they need to ensure their raise is progressing well. For marketed raises, including Regulation A+, Crowdfunding, 506c and Offering Memorandums, DealMaker has a full suite of marketing attribution tools to track the success of the marketing spend.
  • Shareholder Engagement and Management – The DMEngage shareholder management and engagement tool allows companies to share information, news releases and documents with current and potential investors and stakeholders before, during and after the raise. Investors and stakeholders also have access to all their information and documents in a branded portal. Whether it is a testing the waters campaign, uploading a DRS statement or sharing the companies’ latest quarterly results, DMEngage allows companies to manage all non-raise communication and engagement. DealMaker’s extensive research has shown that companies that engage their shareholders and stakeholders regularly raise more and faster and have more successful subsequent rounds.
  • Partners and Expertise – Having completed nearly 1,000 raises, DealMaker has unparalleled experience in capital raising. DealMaker’s customer success team prepares a detailed plan for each raise to ensure no detail is missed and customers are set up for success. DealMaker has also established the largest network of partners in the space. Whether customers need a marketing partner, a financial publisher, a broker dealer, a law firm, an auditor or investor relations, DealMaker can make referrals and ensure they have the right team in place for a successful raise.

Types of Raises

  • Regulation A+, 506c and Crowdfunding – Companies completing marketed raises on DealMaker own their brands and drive investors through a landing page that lives on the companies’ own website. Reg A+, 506c and Crowdfunding are the ultimate marketing tools, allowing companies to engage and grow their customer bases while raising capital. Marketed raises also have access to DealMaker’s best-in-class solutions, including digital payment tools, automated AML checks and Accredited Investor Verification services. As a result, companies raising via Reg A+, Reg CF and 506c on DealMaker have higher average investment amounts and conversion.
  • Seed Rounds, 506b, Accredited Investors and Funds – DealMaker’s solutions for traditional capital raises and funds start with a digitized subscription agreement and proprietary question flow. No matter how complex the raise, DealMaker’s question flow ensures subscription agreements are completed in minutes, with no deficiencies.

Executive Team

DealMaker Co-Founder and CEO Rebecca Kacaba has been honored as one of Lexpert’s ‘Top 40 Under 40’ in the legal field and was recognized as one of North America’s most innovative lawyers by the Financial Times. She practiced law on Bay Street for over 10 years and was co-chair of the Toronto Venture Technology and Emerging Growth Companies Group at a law firm while she worked as an M&A attorney in Canada’s financial district.

The company’s Co-Founder and Chief Strategy Officer, Mat Goldstein has practiced law on Wall Street and Bay Street, also gaining recognition from Financial Times as one of North America’s most innovative lawyers. Prior to launching DealMaker, he built and advised several startup enterprises.

DealMaker’s Chief Technology Officer is Geronimo de Abreu. With experience running his own development firm and scaling numerous companies through startup and growth, Mr. de Abreu has a diverse background in computer engineering, entrepreneurship and business strategy (MBA) to take DealMaker to the next level.

DealMaker’s VP of Sales and Marketing, Michael Werry has over a decade of experience successfully building and leading sales organizations in both the SaaS and financial services industries, ranging from startups to SME’s with over $750 million in annual revenue. He brings a wealth of experience in scaling organizations through periods of exponential growth.

The company’s VP Finance, Frank Jessop is a CFA, CPA, CA with a BMath in Stats from Waterloo. He provided leadership to the PwC emerging growth companies group before leading Sensibill through its Series B over the course of the last five years.

The company is also supported by advisers with decades of experience in the capital markets and their foundational technologies.


Recent News

chart

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX).

  • Lexaria Bioscience (NASDAQ: LEXX) continues to innovate with its DehydraTECH(TM) drug-delivery technology. It is constantly collaborating with research institutions and businesses to identify other new ways to improve its technology. So far, advanced DehydraTECH 2.0 formulations are already being used by the company in ongoing human studies. The technology is already being monetized through commercial use (https://cnw.fm/jPvBr).
    • Lexaria is making progress with research on its DehydraTECH drug delivery technology
    • Advanced 2nd-generation DehydraTECH 2.0 formulations utilized in ongoing hypertension studies
    • The company intends to monetize its technology for commercial use
    • Its quest for commercial success also follows its move to delist from the Canada Securities Exchange (“CSE”) to focus on the Nasdaq listing
  • Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced the results of its antiviral drug molecular characterization study. Lexaria worked with the National Research Council ("NRC"), Canada's premier federally funded research organization, to conduct the study. Results from the NRC confirm the study objectives, including demonstrating that the company’s proprietary DehydraTECH(TM) processing and formulation technology does not create a covalently bonded new molecular entity ("NME"). In addition, the study confirmed that each of the five drugs tested remained stable without undergoing any change in chemical structure. To view the full press release, visit https://ibn.fm/b3trm

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 19 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Thursday’s trading session at $6.87, up 2.9985%, on 150,383 volume. The average volume for the last 3 months is 954,398 and the stock's 52-week low/high is $3.97510004/$9.46000003.

Recent News

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

The QualityStocks Daily Newsletter would like to spotlight Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF).

  • Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, will be hosting a third-quarter virtual Investor Day. The company has scheduled this event for July 29, 2021; it will begin at 9 a.m. PDT. Included on the event agenda will be a presentation by Tryp's management team. The presentation will provide updates regarding the company’s psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program. To register for the event visit, https://ibn.fm/GSUs8. To view the full press release, visit https://ibn.fm/0IOyO
  • An exploratory study that was recently published in the “ACS Pharmacology and Translational Science” journal has found that using mescaline has been linked to improvements in anxiety and depression. Mescaline is a psychedelic hallucinogen derived from the peyote cactus. This study provides evidence that some of the useful effects of mescaline are associated with certain facets of the psychedelic experience. Prior research suggests that the use of classic psychedelics may have long-term positive effects. However, the use of mescaline among Native American tribes hasn’t received as much attention as other substances, such as psilocybin. Mescaline isn’t the only psychedelic compound found to hold promise as a treatment for mental health problems. Other companies, including Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), are looking into other compounds such as psilocybin, for which dozens of studies have established their potential as possible treatments for psychiatric disorders.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is a pharmaceutical company focused on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways.

The company was founded in 2019 and is headquartered in San Diego, California.

Innovative Drug Pipeline

Tryp’s current focus is on advancing its two drug development platforms: its Psilocybin-for-Neuropsychiatric Disorders (PFN™) program targeting fibromyalgia, eating disorders and chronic pain conditions; and razoxane for soft tissue sarcomas. The company intends to explore opportunities to monetize these platforms after generating Phase 2b clinical data.

The company’s development plans cover three strategic initiatives:

  • Develop: Tryp intends to utilize the FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.
  • Protect: Tryp plans to utilize regulatory exclusivity, patents, trade secrets and proprietary know-how to protect the commercial lifespan of its drug candidates.
  • Monetize: Tryp intends to seek out licensing, acquisition and co-development opportunities for drug candidates following their Phase 2 stages of development.

PFN™ Program

Through its PFN™ program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that have distinct advantages over other drugs currently on the market or in development. These advantages include:

  • Increased efficacy
  • Natural blood-brain barrier penetration
  • Enhanced safety and toxicity profiles
  • Reduced risk of abuse
  • Reduced risk of addiction

Tryp’s PFN™ program features its lead drug candidate, TRP-8802. The company’s initial indication for TRP-8802 is fibromyalgia.

Fibromyalgia is believed to be a neurosensory disorder characterized in part by abnormalities in pain processing by the central nervous system. The three drugs with FDA approval for the treatment of fibromyalgia are Pregabalin (Lyrica®), Duloxetine (Cymbalta®) and Milnacipran (Savella®), which are only effective for a portion of patients suffering from the condition.

Tryp plans to seek FDA approval to proceed directly to Phase 2 clinical trials evaluating TRP-8802 as a treatment for fibromyalgia based on existing preclinical and clinical data for the active pharmaceutical ingredients in TRP-8802.

Tryp’s pipeline of indications for TRP-8802 also includes eating disorders and certain forms of chronic pain. The company expects to initiate Phase 2a clinical trials in these areas in 2021.

Tryp recently partnered with Albany Molecular Research Inc. (“AMRI”) for the manufacture of the company’s synthetic psilocybin using proprietary methods. AMRI has initiated the process of manufacturing a 200g non-GMP demonstration batch of psilocybin and will produce a batch of GMP psilocybin in mid-2021. As the holder of the Drug Master File, Tryp expects to be the only U.S.-based manufacturer of synthetic psilocybin in the industry.

Razoxane

Tryp’s second drug candidate, TRP-1001 (razoxane), is being developed as a treatment for soft tissue sarcomas and has been evaluated in multiple Phase 2 clinical trials conducted by clinicians unaffiliated with Tryp. The company believes that existing clinical data regarding razoxane will likely allow TRP-1001 to be studied in a Phase 2 trial without the need for extensive preclinical or Phase 1 trials.

Sarcomas are rare tumors that are derived from connective tissues in the body and comprise 7% of all cancers in children. In 2018, an estimated 13,000 new cases of soft tissue sarcoma were diagnosed, with the tumors resulting in over 5,000 deaths during that year in the United States alone (https://ibn.fm/nWOGq).

Market Outlook

With its drug development programs targeting multiple indications, Tryp is well positioned to capitalize on growth opportunities spanning a range of therapeutic markets. The global oncology drugs market, in particular, represents a sizable opportunity.

In 2018, oncology indications accounted for 25% of all drug sales, representing approximately $151 billion in market revenues. By 2024, spending on oncology-targeted therapeutics is expected to top $200 billion and account for roughly 30% of total drug sales, according to a study by Cowen Equity Research (https://ibn.fm/9iZhM).

Valued at $764 million in 2020, the global fibromyalgia treatment market presents unique opportunities for development due to the limited number of approved therapies. With treatment trending upward, the market is expected to grow at a CAGR of 9.2% and reach $1.4 billion in value by 2027 (https://ibn.fm/G66e7).

Management Team

Greg McKee is the Chairman and CEO of Tryp Therapeutics. He has more than 20 years of life sciences management and venture investment experience that he brings to the company. Before taking his role at Tryp, he was the founder of Torrent Ventures, an early-stage digital health and medical technology venture fund. Mr. McKee also served as the CEO of CONNECT, the largest Southern California start-up accelerator. Before this, he was the chairman, president and CEO of then publicly traded Nventa Biopharmaceuticals, which successfully merged with Akela Pharma. Mr. McKee earned a B.A. in Economics from the University of Washington, an M.A. in International Studies from The Joseph H. Lauder Institute, and an MBA from the Wharton School at the University of Pennsylvania. He has been a member of the Young President’s Organization (YPO) since 2006.

James Gilligan, Ph.D., is the company’s President and Chief Science Officer. He has over 35 years of experience in the life sciences industry, including research and development, clinical development, international regulatory affairs and manufacturing. Before joining Tryp, Dr. Gilligan was the Co-Founder and Managing Partner of The Bracken Group, a life sciences consulting firm. He was also the Co-Founder of Unigene Laboratories, which develops technology for the recombinant manufacture of peptide hormones. Dr. Gilligan received his Ph.D. in Pharmacology from the University of Connecticut and a MSIB from Seton Hall University. He continued his post-graduate education at the Roche Institute of Molecular Biology.

Tom D’Orazio is the Chief Operating Officer of Tryp Therapeutics. He has extensive experience in leading the development and commercialization of vaccines, drugs, radiopharmaceuticals and biologics. His prior leadership experience has been in commercial planning, marketing, partnership and business development roles. He was formerly the CEO of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), where he led the transition from a private company to a public one. He co-founded and served as CEO of Superna Life Sciences, a specialty-pharma company focusing on niche drugs for cancer patients in Canada. Mr. D’Orazio has an MBA from Vanderbilt University with a primary focus in both finance and marketing and a B.Sc. in chemistry from Loyola University of Chicago.

Luke Hayes is the company’s Chief Financial Officer. He has played an active role in the life science industry for over 20 years with technology transfer, venture capital and finance experience. His career started with business development for Dow Chemical (NYSE: DOW), with responsibility for pharmaceutical customers such as Eli Lilly and AbbVie. Mr. Hayes has spent more than a decade doing venture capital investing while supporting companies as a director and advisor. He earned a B.S. in Chemical Engineering from Brigham Young University and an MBA from the UCLA Anderson School of Management.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), closed Thursday’s trading session at $0.4124, up 0.585366%, on 96,136 volume. The average volume for the last 3 months is 82,931 and the stock's 52-week low/high is $0.370000004/$1.03999996.

Recent News

ISW Holdings Inc. (OTC: ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings Inc. (OTC: ISWH).

There is little debate that the crackdown on cryptocurrency mining in China has significantly disrupted the markets and dampened sentiment towards digital currencies. What is more open for discussion is the rationale undergirding Beijing’s mandates to shutter the vast majority of its cryptocurrency miners, companies using warehouses of computers guzzling electricity to solve complicated math problems integral to the process of creating new coins and keeping the immutable digital ledger of transactions known as the blockchain. Ahead of the crackdown, 50-60% of all crypto mining activity transpired in China. A top producer of greenhouse gas emissions, Chinese provinces are under directives to slash pollution, for which crypto mining is a contributor. There is also speculation that the People’s Bank of China wants to be the first developed nation with its own digital currency, which would mean it doesn’t want to compete with Bitcoin. Regardless of the motivation, sweeping legislation has ordered miners out of the country, which will be a boon for the U.S. and Canadian cryptocurrency markets going forward. That’s good news for companies such as ISW Holdings Inc. (OTC: ISWH) (Profile), which specializes in mining and portable, renewable-energy powered mining centers.

ISW Holdings Inc. (OTC: ISWH), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings Inc. (ISWH), closed Thursday’s trading session at $0.58625, up 4.7811%, on 765,144 volume. The average volume for the last 3 months is 798,057 and the stock's 52-week low/high is $0.0152/$1.47000002.

Recent News

Healthy Extracts Inc. (HYEX)

The QualityStocks Daily Newsletter would like to spotlight Healthy Extracts Inc. (HYEX).

Healthy Extracts (OTCQB: HYEX), a leading developer and manufacturer of heart health, brain health and supplementary technologies, announced that its new weekly talk show is scheduled to premiere on Clubhouse, a new type of social network based on voice. The increasingly popular channel enables millions of people around the world to gather to talk, listen and learn from each other in real time. The talk show, titled “Activate Your Superhuman Mind,” will cover a range of topics focused on achieving superior mental focus and energy. To view the show, visit https://ibn.fm/48cF7. To view the full press release, visit https://ibn.fm/Z6TMQ

Healthy Extracts Inc. (HYEX) Healthy Extracts Inc. (HYEX), through its growing portfolio of wholly owned subsidiaries, is engaged in the proprietary research and development of natural plant-based formulations, sales, and distribution of cardiovascular and neuro products. The company’s focus is to advance its market positions in the broader health industry through the unique assets and operations of its science-based BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries and to offer better lifestyles through superior health technology.

BergaMet North America

BergaMet NA is engaged in the sale and distribution of a full line of proprietary product formulations derived from the rare Citrus Bergamot SuperFruit™ called “bergamot.” Bergamot is native to Southern Italy and is naturally sourced and uniquely loaded with various antioxidant polyphenols. Thanks to this composition, bergamot supports and promotes overall wellness specific to cholesterol, cardiovascular and metabolic health with no known side effects.

BergaMet NA is the only Citrus Bergamot SuperFruit™ heart health supplement backed by 17 clinical studies. The BergaMet brand supplement boasts the highest quality and concentration of polyphenols and flavonoids available anywhere in the world. It is also the only bergamot supplement approved by the prestigious Accademia del Bergamotto of Italy. BergaMet NA is the only company authorized to manufacture, distribute and sell these products in the United States, Canada and Mexico.

Consumers are including the Citrus Bergamot SuperFruit™ in their everyday personal health programs. The clinically proven antioxidant provides benefits to tens of thousands of people daily.

The company’s line of products can be found at www.bergametna.com, through Amazon, other online retailers and in doctors’ offices throughout the United States.

The BergaMet Advantage

BergaMet has been studied in 17 published clinical trials which reported results of lower LDL cholesterol, higher HDL cholesterol, lower triglycerides, lower blood pressure, lower blood glucose, increased arterial function, improved liver function and is effective as a complement to statin use.

Cardiovascular disease is the number one cause of death in the U.S. and worldwide, claiming nearly 18 million lives each year accounting for 31% of all global deaths. In the U.S., statins are one of the most commonly prescribed medicines for cardiovascular disease. The Centers for Disease Control estimates that 28% of American women and men over the age of 40 take a statin to lower the amount of cholesterol in the blood.

Taking aim at this market for cardiovascular care, BergaMet NA continues to advance the awareness of its medical-grade supplements and separate its formulation from competitors.

BergaMet NA products contain 47% BPF (bergamot polyphenolic fraction), while its closest competitors have only 38%. The company’s increased dosages (600-675mg vs 500mg) and 47% BPF are clinically proven to be more effective in improving heart health and metabolic syndrome.

BergaMet Citrus Bergamot SuperFruit™ supplements:

  • Support healthy immune systems with powerful antioxidants and proprietary formulations.
  • Reduce cholesterol and support healthy glucose and blood pressure levels.
  • Are fully organic, vegan-friendly and dairy, gluten, soy and GMO-free.
  • Contain five key unique flavonoids that make up the most powerful 47% BPF (bergamot polyphenolic fraction) in the world, providing superior results compared to their competitors.
  • Have been clinically shown to increase arterial elasticity while reducing arterial and muscle inflammation.

Ultimate Brain Nutrients

Healthy Extracts’ Ultimate Brain Nutrients (“UBN”) subsidiary is a science-based company that develops unique, plant-based superior health technology neuro-products that improve brain health, including memory, cognition, focus and neuro-energy.

UBN’s KETONOMICS® proprietary formulations – targeting brain activity, focus, headache and cognitive behavior — provide multiple intellectual property license opportunities for monetizing the company’s portfolio.

License opportunities include multiple beverage formats, individual products, proprietary mixtures and other food platforms.

UBN has five unique formulation patents – one issued and four pending – targeting brain activity, focus, headache and cognitive behavior.

The UBN Advantage

UBN’s all-natural, sugar-free and caffeine-free proprietary formulations are the result of 20 years of scientific research and are positioned to provide consumer neuro-products that are natural brain solutions. UBN has filed for approval to the U.S. Food and Drug Administration (FDA) to make a Qualified Health Claim for its migraine formulation, tapping into consumer demands for healthy beverages that contribute to brain health, overall well-being and performance.

Over 50 million Americans consume unhealthy energy shots and drinks each day, while the neuro/energy market generates over $10 billion per year in revenue. Within this growing market, UBN is advancing its position to meet rising consumer demand for healthy, science-based options. The company’s KETONOMICS® proprietary formulations have been proven to naturally elevate brain energy and function, including memory, cognition and focus.

UBN’s KETONOMICS® supplementation has also been studied in sports physiology, with specific regard to its potential benefits for competitive performance and endurance.

Healthy Extracts Executive Team

Kevin “Duke” Pitts, Director, President and Chief Operating Officer

  • Started and built from the ground up two multi-million-dollar businesses, one of which grew into a Top 100 retailers in the U.S.
  • Unique management skills led to the development of successful teams for 35 years
  • Pioneered direct marketing for a Fortune 200 company, creating a 20% increase in targeted incremental sales
  • Founded Einstein’s Hemp, which developed and brought to market one of the only odorless and tasteless water-soluble CBD products in the world
  • Developed and implemented digital/guerrilla marketing strategies for public and private companies focused on long-term brand position and acquisition efforts
  • Specialized in customer relationship management (CRM) tools for creating the best customer experiences
  • Worked in publicly traded industries for 10 years, overseeing up to $20 million in annual marketing budgets

William “Bill” Bossung, Director, Chief Financial Officer

  • 35 years of diverse experience in corporate finance, insurance and accounting
  • 20 years of experience with IPOs focusing on audits, FINRA and SEC regulations
  • Specializes in the formation of capital raising over $100 million, recently raising $12 million for Splash Beverage
  • Specializes in upgrading penny stocks companies to the NYSE or Nasdaq
  • Involved in 30+ companies transitioning from private to public identities
  • Founded several companies, including BCF Technology Inc., which sold to Vertafore; managing partner at Bishop Equity Partners LLC; director at Splash Beverage Group; and director of finance at Chadmoore Wireless, where he licensed channels to Nextel for $162 million

Bill Croyle, Director, Private Investor and Accomplished Senior Executive

  • More than 40 years of success in the IT, energy, manufacturing, telecommunications, venture capital and finance industries
  • Broad expertise includes negotiating mergers and acquisitions, as well as service and delivery contracts
  • Formerly was a founder, owner or executive of EnTX Group; Impact Legacy Partners; FB Oilfield Special Tools; and Western Energy Advisors

Dr. Gerald Haase, Chief Medical Officer

  • Clinical professor of surgery at the University of Colorado, School of Medicine
  • Actively involved in medical research and clinical trials for 35 years
  • Received U-10 grant funding from the National Institutes of Health cooperative group clinical trials program, as well as U.S. Congressional funding for Cooperative Research and Development Agreements with the Department of Defense and NASA
  • Was chairman of the Department of Pediatric Surgery at Children’s Hospital Colorado; consultant surgeon to the Department of the Army; vice-chairman of the Children’s Cancer Group, a cooperative research consortium of the National Cancer Institute; on the National Board of Directors of the American Cancer Society; a senior member of the Commission on Cancer of the American College of Surgeons; and a member of the editorial board of The Annals of Surgical Oncology
  • Has published 180 scientific papers and is the inventor or co-inventor of 12 issued U.S. patents for micronutrient and phytonutrient therapy, with five pending patents
  • Recipient of clinical research grants and contracts funded at a several million-dollar cumulative level
  • Is an editorial reviewer for medical journals and a member of numerous professional societies, including the American Association for Cancer Research, International College of Surgeons, American Academy of Pediatrics, New York Academy of Sciences and American College of Physician Executives

Healthy Extracts Inc. (HYEX), closed Thursday’s trading session at $0.095, up 26.6667%, on 4,886 volume. The average volume for the last 3 months is 11,651 and the stock's 52-week low/high is $0.052000001/$0.100000001.

Recent News

Sustainable Green Team Ltd. (SGTM)

The QualityStocks Daily Newsletter would like to spotlight Sustainable Green Team Ltd. (SGTM).

  • In the midst of record heat across the country, smart landscape professionals and gardeners are taking advantage of the benefits of mulch, which include helping the soil retain moisture so less watering is needed (https://ibn.fm/dY9zu). Sustainable Green Team (OTC: SGTM) and its wholly owned subsidiary Mulch Manufacturing Inc. offer a wide variety of mulch products designed to provide consumers with benefits during the heat of the summer as well as all year long.
    • Adding mulch to gardens, landscapes provides numerous advantages, including water conservation and environmental sustainability
    • SGTM was developed by combining resources of three companies that are leaders in their specialties
    • Mulch Manufacturing has product line. distribution system to address substantial customer base with significant expansion potential
  • Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is passionate and dedicated to the environment, a stance it held even before the management realized massive financial success. “Through its various subsidiaries, SGTM diverts natural waste created by devastating storms and transforms it into organic, environmentally beneficial products such as gardening mulch and playground surfacing materials,” reads a recent article. To view the full article, visit https://ibn.fm/XPE1v

Sustainable Green Team Ltd. (OTC: SGTM), through its subsidiaries, including National Storm Recovery LLC (DBA Central Florida Arbor Care and Mulch Manufacturing Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

SGTM and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

SGTM’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

SGTM in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides SGTM with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

SGTM’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

SGTM plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as its flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow SGTM’s debris hauling division to realize significant savings on its transportation costs.

SGTM has chosen as its new headquarters the 100,000-square-foot Mulch Manufacturing building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing Inc. and National Storm Recovery LLC and has ample room to expand as needed.

Leadership

SGTM’s leadership team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

Sustainable Green Team Ltd. (OTC: SGTM), closed Thursday’s trading session at $1.15. The average volume for the last 3 months is 1,122 and the stock's 52-week low/high is $0.200000002/$7.00.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

  • A milestone has been reached in the quest to create a new rare earth supply chain based in the United States. Energy Fuels (NYSE American: UUUU) (TSX: EFR) and Neo Performance Materials (TSX: NEO) have announced that the first container of mixed rare earth ("RE") carbonate has been shipped from UUUU’s White Mesa Mill in Utah to NEO’s rare earth separation facility in Estonia, creating a new United States-to-Europe rare earth supply chain.
    • The first container of mixed RE carbonate has been shipped from the United States to Europe.
    • The announcement marks important achievement, not only for UUUU and NEO, but also for U.S. government efforts to restore critical rare earth supply chains.
    • Energy Fuels is the only North American company that currently produces a monazite-derived, enhanced rare earth material.
  • Energy Fuels (NYSE American: UUUU) (TSX: EFR) and International Consolidated Uranium Inc. (TSX.V: CUR) (OTCQB: CURUF) today announced that CUR has entered into a definitive asset purchase agreement with certain wholly owned subsidiaries of Energy Fuels (collectively, the “EF parties”). Under the agreement, CUR will acquire a portfolio of conventional uranium projects located in Utah and Colorado (the “projects”) from the EF parties (collectively, the “transaction”). In connection with the closing of the transaction, the companies have also agreed to enter into toll-milling and operating agreements with respect to the projects, which positions CUR as a potential near-term U.S. Uranium producer subject to an improvement in uranium market conditions and/or CUR entering into acceptable uranium supply agreements. To view the full press release, visit https://ibn.fm/l6UXH

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Thursday’s trading session at $0.3974, off by 2.6934%, on 16,565 volume. The average volume for the last 3 months is 71,479 and the stock's 52-week low/high is $0.200100004/$0.870000004.

Recent News

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)

The QualityStocks Daily Newsletter would like to spotlight GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF).

A recent study may have found the reason why gold is usually discovered around arsenic. The study, which involved geochemists from various institutions across the globe, may help explain why miners of the precious metal may be more at risk of arsenic poisoning. The study’s findings were presented at the annual global Goldschmidt Conference, which focuses on geochemistry and other associated sciences. The findings were also published in a report in the “Geochemical Perspectives Letters.” It looks like there is so much to learn about gold, and it wouldn’t be surprising to find that precious metals extractors such as GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) continue to learn and discover new things about this shiny metal as the years go by.

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.

Chilean Gold Properties Being Acquired

On April 17, 2020, GoldHaven Resources entered into an agreement to purchase a 100% interest in two gold projects located in the Maricunga Gold Belt of Northern Chile. The first property, Rio Loa, is located 25 kilometers south of Gold Fields Ltd.’s Salares Norte, where, this year, a five-million-ounce discovery was made. The second property, Coya, is located only 10 kilometers east of the Kinross La Coipa open pit mine, which has produced over 7.5 million ounces of gold to date.

Rio Loa Project

Initial geophysical studies of the Rio Loa site have exposed highly anomalous ardennite and lead values, a key characteristic of gold mineralization within silicified resistive bodies. The studies have also produced initial findings which are similar to those seen at contiguous mines, such as Salares Norte (operated by Gold Fields), which has over five million ounces in estimated gold deposits.

The potential economics for the site look particularly promising when taking the unit costs at the neighboring Salares Norte mine into account. Gold Fields has estimated that its production AISC (all-in sustainable costs) will approximate $552 per ounce and have forecast a 2.3-year payback period for its initial investment, assuming a $1,300 per ounce gold price.

Coya Project

The Coya site is located within close proximity to one of the richest and largest epithermal gold and silver districts in Chile and is in close proximity to active mining sites, specifically the La Coipa mine owned by Kinross. A study carried out in 2017-2018 on the Coya site of 796 rock chip samples found favorable gold and silver values, in some cases ranking as high as 764 grams/tonne of gold and 719 grams/tonne of silver – values which are near certain indicators of potential gold and silver deposits. The La Coipa mine (Kinross) has produced over 6.9 million ounces of gold to date.

On August 11, 2020, GoldHaven Resources acquired five potential gold projects in the Maricunga Gold Belt of Northern Chile. The Maricunga hosts discoveries within the last 10 years of over 100 million ounces of gold and over 450 million ounces of silver. These newly acquired properties are in close proximity to seven other mines, which possess an estimated aggregate of 81 million ounces of gold in total reserves.

GoldHaven’s five new projects cover a total area of approximately 22,600 hectares, or 226 square kilometers, located in the northern portion of the Maricunga Belt in proximity to the 5 million-ounce gold equivalent Salares Norte project owned by Gold Fields. Gold Fields announced in April 2020 its intention to proceed with the development of Salares Norte at a cost of $860 million, with a $138 million expenditure budgeted for 2020.

The Maricunga Belt extends approximately 150 kilometers north-south and 30 kilometers east-west, straddling the border between Chile and Argentina. This region hosts known mineral resources of more than 100 million ounces of gold, 450 million ounces of silver and 1.3 billion pounds of copper.

The Maricunga project’s opportunity came about as a result of a $150 million initiative launched by the Chilean Economic Development Agency (“CORFO”), with the objective of encouraging exploration and mining prosperity in Chile and strengthening Chile’s position as a world leader in the sector.

As part of CORFO’s program, a total of $15.3 million was given to private equity fund IMT Exploration to evaluate 403 projects, beginning in 2011. This led to a generative program carried out from 2016 to 2019, resulting in 126 potential epithermal targets from which 57 field evaluations were made. Due diligence work followed on 19 of these. Work programs were then conducted, including geological mapping, rock and soil sampling and TerraSpec (PIMA) analyses on geochemical grids for alteration mapping, and, as a result, the five high-priority Maricunga projects were identified. No drilling has been carried out on any of the Maricunga projects.

Securing Financing for Upcoming Operations

In conjunction with its announcement regarding its acquisition of five Chilean mining interests, GoldHaven Resources also detailed plans for a non-brokered private placement of 11.5 million units at a price of $0.35 per unit, for gross proceeds of $4,025,000. Each unit will consist of one share of the company and one warrant, the latter of which can be exercised to acquire an additional share of the company for a period of 18 months from the date of issuance at a price of $0.50 per share. Net proceeds from the offering are intended to be used to fund general expenses, as well as exploration and drilling of its mineral properties.

Gold Prices Hit Record High in 2020

Gold prices have been on a remarkable run in 2020, breaking above $2,000 per ounce for the first time on record. Having begun the year at $1,515 per ounce, the precious metal has seen a huge surge on the back of widespread economic uncertainty stemming from governments’ worldwide propensity to expand the money supply, from the reduction of the value of the U.S. dollar as expressed by the decrease in the U.S. dollar index, and from the very real economic effects of the COVID-19 pandemic.

Global central banks have carried out 144 interest rate cuts thus far in 2020, reducing rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures has prompted a number of investment banks to boost their near-term outlooks for gold prices, with Bank of America raising its 18-month gold price target to $3,000 per ounce (http://nnw.fm/PQJtc).

Leadership Team

David Smith, President, CEO and Director, has been immersed in the mining industry for the last eight years, working in corporate development and finance. Prior to GoldHaven Resources, Smith cofounded a multifaceted real estate development and sales company, which has now been in operation for over 35 years. He also cofounded two successful environment-focused companies listed on the Toronto Stock Exchange. Both companies were sold independently and returned a significant profit for shareholders.

Darryl Jones, Chief Financial Officer, is a finance executive and CPA with over 30 years of public company and project buildout experience. Most recently, Jones served as the CFO of Lupaka Gold Corp., retiring in June 2018. Prior to that, Jones serves as CFO of Corriente Resources, which was sold to CRCC-Tongguan in May 2010 for C$680 million.

Patrick Burns, VP Exploration and Director, is a Canadian geologist with over 40 years of experience throughout the Caribbean and Central and South America. He played a direct role in the discovery of the Escondida porphyry copper deposit in Chile and has been involved in publicly traded mining companies, predominantly in Chile, for 35 years.

Marla Ritchie, Corporate Secretary, brings over 25 years of experience in public markets to the GoldHaven team. Throughout this time, she has worked as an administrator and corporate secretary specializing in resource-based exploration companies. Currently, Ritchie is the corporate secretary for several companies, including International Tower Hill Mines Ltd. and Trevali Mining Corp.

Gordon Ellis, Director; has over 50 years’ experience in mining and resource development. A professional engineer and entrepreneur, he has held multiple senior management and director roles with public mining companies, as well as a multi-billion-dollar ETF fund. Ellis holds an MBA in international finance and a Chartered Directors designation.

Scott Dunbar, Director is a professor and head of multiple departments at the University of British Columbia, including mineral extraction and mining innovation, as well as mining engineering. He has been involved in projects around the world in regard to mining exploration, geotechnical engineering and mine design. Dunbar received his PhD in geophysics and civil engineering from Stanford University.

GoldHaven Resources Corp. (OTCQB: GHVNF), closed Thursday’s trading session at $0.3974, off by 2.6934%, on 16,565 volume. The average volume for the last 3 months is 71,479 and the stock's 52-week low/high is $0.200100004/$0.870000004.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in direct-selling and other sectors, and its newest brand — Hapi Travel Destinations — are gearing up to enroll distributors and customers. In preparation, the company is finalizing its branding efforts, including releasing a new logo and tagline, as well as a stunning new video; plans for the unveiling of the travel company’s website are imminent (https://ibn.fm/cT6Iq).

  • Hapi Travel Destinations finalizes branding efforts, releases stunning travel video
  • All the pieces for a successful launch are falling into place as consumers are starting to re-engage with travel
  • The new company will offer members unfettered access to tremendous savings, exclusive benefits

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Thursday’s trading session at $0.15, off by 2.9126%, on 17,291 volume. The average volume for the last 3 months is 119,480 and the stock's 52-week low/high is $0.122500002/$0.730000019.

Recent News

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies Inc. (OTC: INND) was featured in a publication detailing various investment considerations and how the company is “One to Watch.”

  • InnerScope is a direct-to-consumer manufacturer, distributor and retailer of FDA-registered Bluetooth app-controlled self-adjusting hearing aids and personal sound amplifiers products, doctor-formulated dietary hearing and tinnitus supplements, and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems
  • The company provides ear care and cleaning solutions for a total packaged service
  • Free hearing testing can be completed on the company’s website and on the app to determine if hearing loss has occurred and if a hearing aid or sound amplification device is the best fit
  • The company’s self-service fully automated hearing screening kiosks target an additional 41 million Americans who may not have access to an audiologist – also doubling as a point-of-sale system for the InnerScope hearing aid products
  • InnerScope’s self-service fully automated hearing screening kiosks will be deployed in big box retailers, grocery stores, pharmacies and other public spaces; InnerScope has received interest from dozens of businesses and has already numerous signed contracts to launch hearing screening kiosks in the coming months in over nine states
  • InnerScope has been in the retail hearing device business for over 70 years; each member of its management team started in the industry at an early age

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb).

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Thursday’s trading session at $0.01251, off by 1.4961%, on 100,651,057 volume. The average volume for the last 3 months is 61.613M and the stock's 52-week low/high is $0.000000999/$0.097999997.

Recent News

Hero Technologies Inc. (OTC: HENC)

The QualityStocks Daily Newsletter would like to spotlight Hero Technologies Inc. (OTC: HENC).

Ever heard of aeroponics? Well, if you haven’t, it is the process of growing plants in a mist or air environment without using soil. Instead of using soil, the roots dangle in the air and are sprayed with solutions laden with nutrients needed for growth, using specially designed devices. Aeroponic systems utilize soilless growing mediums, liquid nutrients and water to efficiently and quickly grow nutritious produce. Cannabis companies such as Hero Technologies Inc. (OTC: HENC) have taken to growing marijuana using aeroponics, and this not only produces high-quality yields but also lowers the possible adverse ecological effects of marijuana growing.

Hero Technologies Inc. (OTC: HENC) is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries that make the organization a multi-state operator (MSO).

The company was founded in 2004 and is headquartered in Dover, Delaware.

Portfolio

The company holds the majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation firm focused on providing optimal conditions to enhance photosynthesis and cultivation. Hero Technologies is planning expansion in cultivation and dispensary operations in Colorado through wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.

Hero Technologies also owns and operates HighlyRelaxing.com under Highly Relaxing LLC and recently acquired the assets of V Brokers LLC, now operating as Veteran Hemp Co. at VeteranHempCo.com.

BlackBox Systems and Technologies LLC

BlackBox Systems and Technologies LLC markets a proprietary cannabis aeroponic cultivation system designed for the large-scale production of top-shelf cannabis products. BlackBox offers the optimal conditions to enhance photosynthesis and promote the cultivation of large flowering plants. The system’s dry room, process room and secure storage were designed for precise control through each phase of the cannabis lifecycle. Weekly harvests are achieved using 13 separate BlackBox systems in independent modules.

The system provides a series of key benefits, including:

  • High-pressure nutrient delivery, with no nutrient or PH deficiencies
  • Sterile, 100% nutrient solution
  • Drain to Waste (no reuse of wastewater)
  • Low water usage (1 gallon per plant per day)
  • Constant PH and EC in reservoirs
  • Modular design (1 to 100 pods in any configuration)
  • Innovative proprietary engineering
  • Minimal cleanup
  • Media-less growing, suspended in the air, with no media waste
  • No pesticides

Highly Relaxing LLC

Highly Relaxing LLC is an emerging Henderson, Nevada-based operation dedicated to providing customers with honestly labeled, high-quality hemp-derived CBD products. Its current offerings include a topical CBD cream that provides localized relief from potential discomfort.

Veteran Hemp Co.

Veteran Hemp Co.’s mission is to provide a quality, consistent and delicious product for Americans looking to enjoy the hemp smoking experience. Its product is brought in by only the finest farming operations delivering the best genetics. Veteran Hemp Co. has its own custom harvest plans, drying facilities and all of the logistics that fall between. Veteran Hemp Co. prides itself on being a veteran-approved company.

Market Outlook

The global legal cannabis market is anticipated to reach $84 billion by 2028, expanding at a CAGR of 14.3% from 2021 to 2028. The driving factor for this forecast expansion is the increasingly widespread legalization of cannabis for medical and recreational use. Recreational use accounted for 60.3% of industry revenue in 2020.

North America provided the largest revenue share in the cannabis market, accounting for 91.1% of the global market in 2020. Due to the early legalization of medical and recreational cannabis in the region, the customer pool has increased exponentially (https://nnw.fm/snpHh).

The global CBD market was valued at $2.8 billion in 2020 and is expected to grow at a CAGR of 21.2% and reach $13.4 billion by 2028. North America is considered the most progressive region for cannabis and its derived products, with the highest number of CBD companies being based on the continent. The B2B (business to business) segment dominates the CBD industry, accounting for the largest revenue share at 59.6% in 2020 (https://nnw.fm/cGxXQ).

With its vertically integrated business model and development into a multi-state operator across multiple sectors of the cannabis industry, Hero Technologies is uniquely positioned to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers.

Management Team

Gina Serkasevich, CPA, CMA, is the Chief Executive Officer, Treasurer and Secretary of the Hero Technologies. She previously worked for Holloman Corporation as its Director of Finance beginning in June 2012 and was appointed Chief Financial Officer of Holloman Energy Corporation in August 2014. She has more than 30 years of domestic and international corporate accounting and finance experience. She served as U.S. Controller for EFLO Energy Inc., a company focused on the acquisition, exploration and development of oil and gas assets in North America. Prior to 2012, Ms. Serkasevich worked in the oil and gas tanker transportation industry as a Regional Financial Manager for AET Inc. Limited (2011-2012), as a Financial Consultant for OSG Ship Management Inc. (2009-2011) and as a Financial Controller/CFO for Stena Bulk LLC (1998-2008). During her 11-year tenure at Stena Bulk LLC, she established the financial, accounting and reporting requirements for its new joint ventures and tanker pools with Sonanagol USA and held the Company Secretary position on both of those companies’ boards of directors.

Dan McCarthy is the company’s Corporate Development Manager. He has spent more than 12 years in the institutional investment community, holding various investment banking and private equity executive roles. Thus far, he has been a part of over $1 billion in transactional value ranging from debt and equity to acquisitions and diversities throughout his career. Mr. McCarthy’s most recent role was Managing Director at Petro Capital, a Dallas-based private equity and investment bank. He began his career working for a private international consulting firm based in Washington, D.C., helping corporations and funds expand into non-G7 countries utilizing World Bank financing. He is also a graduate of the University of Kansas School of Business and completed the Mergers and Acquisitions program at the New York Institute of Finance.

James Rowland is Hero Technologies’ Marketing Advisor and an expert in marketing and e-commerce. He has held many high-level marketing and business-related roles. He is the Founder and current CEO of PerfectCheckout.com and the current Business Development Specialist at Fulfillment.com. Mr. Rowland has held multiple high-level positions throughout his career, which have provided him with the experience needed to bring success-backed marketing leadership skills to his current role with the company.

Hero Technologies Inc. (HENC), closed Thursday’s trading session at $0.0686, off by 3.8812%, on 64,937 volume. The average volume for the last 3 months is 255,915 and the stock's 52-week low/high is $0.0236/$0.317400008.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

In a series of strategic acquisitions, Sugarmade Inc. (OTC: SGMD) has strengthened its position as a growing presence in the California cannabis sector. The company, which is currently a central player in the state’s expanding cannabis delivery space, is focused on developing a full farm-to-door vertically integrated cannabis business.

  • Most recently SGMD signed MOU to obtain three non-storefront California cannabis licenses.
  • Sugarmade plans to open three new Nug Avenue cannabis delivery hubs in the Los Angeles metro area.
  • In May, the company completed the acquisition of Lemon Glow Company Inc., along with all of its assets, interests, property and rights.

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.

Management

Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Thursday’s trading session at $0.002035, off by 7.5%, on 171,759,103 volume. The average volume for the last 3 months is 130.839M and the stock's 52-week low/high is $0.000699999/$0.019999999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading